Lista de obras -

A Diagnostic Score for Insulin Resistance in Nondiabetic Patients with Ischemic Stroke or Transient Ischemic Attack

artículo científico publicado en 2016

Achievement of Guideline-Recommended Weight Loss Among Patients With Ischemic Stroke and Obesity

scientific article published on 01 March 2019

Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus

artículo científico

Distance from Home to Research Center: A Barrier to In-Person Visits but Not Treatment Adherence in a Stroke Trial.

artículo científico publicado en 2018

Effects of pioglitazone on cognitive function in patients with a recent ischaemic stroke or TIA: a report from the IRIS trial

artículo científico publicado en 2017

Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS.

artículo científico publicado en 2017

Genetic risk factors for pediatric-onset multiple sclerosis

artículo científico publicado en 2017

Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone

artículo científico publicado en 2018

IQ predictors in pediatric opsoclonus myoclonus syndrome: a large international cohort study

artículo científico publicado en 2020

Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease

artículo científico publicado en 2016

Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke).

artículo científico publicado en 2017

Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial

artículo científico publicado en 2019

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

artículo científico publicado en 2016

Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial

artículo científico publicado en 2016

Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial

artículo científico publicado en 2014

Scoring System to Optimize Pioglitazone Therapy After Stroke Based on Fracture Risk

scientific article published on 10 December 2018

Smoking cessation and outcome after ischemic stroke or TIA.

artículo científico publicado en 2017

Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction.

artículo científico publicado en 2017

Lista de obras de

A Diagnostic Score for Insulin Resistance in Nondiabetic Patients with Ischemic Stroke or Transient Ischemic Attack

Achievement of Guideline-Recommended Weight Loss Among Patients With Ischemic Stroke and Obesity

Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus

Distance from Home to Research Center: A Barrier to In-Person Visits but Not Treatment Adherence in a Stroke Trial.

Effects of pioglitazone on cognitive function in patients with a recent ischaemic stroke or TIA: a report from the IRIS trial

Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS.

Genetic risk factors for pediatric-onset multiple sclerosis

Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone

IQ predictors in pediatric opsoclonus myoclonus syndrome: a large international cohort study

Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease

Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke).

Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial

Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial

Scoring System to Optimize Pioglitazone Therapy After Stroke Based on Fracture Risk

Smoking cessation and outcome after ischemic stroke or TIA.

Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction.